These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34407765)

  • 1. Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations.
    Szeponik L; Ahlmanner F; Sundström P; Rodin W; Gustavsson B; Bexe Lindskog E; Wettergren Y; Quiding-Järbrink M
    BMC Immunol; 2021 Aug; 22(1):58. PubMed ID: 34407765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells.
    Scurr M; Ladell K; Besneux M; Christian A; Hockey T; Smart K; Bridgeman H; Hargest R; Phillips S; Davies M; Price D; Gallimore A; Godkin A
    Mucosal Immunol; 2014 Mar; 7(2):428-39. PubMed ID: 24064667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
    Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
    Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating gluten-specific FOXP3
    Cook L; Munier CML; Seddiki N; van Bockel D; Ontiveros N; Hardy MY; Gillies JK; Levings MK; Reid HH; Petersen J; Rossjohn J; Anderson RP; Zaunders JJ; Tye-Din JA; Kelleher AD
    J Allergy Clin Immunol; 2017 Dec; 140(6):1592-1603.e8. PubMed ID: 28283419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypical and functional characteristic of FoxP3(+);CD39(+); regulatory T cells in humans].
    Huang HH; Wang SY; Wang HF; Fu JL; Han P; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):536-8. PubMed ID: 20487644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39
    Ahlmanner F; Sundström P; Akeus P; Eklöf J; Börjesson L; Gustavsson B; Lindskog EB; Raghavan S; Quiding-Järbrink M
    Oncotarget; 2018 Dec; 9(97):36993-37007. PubMed ID: 30651930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes.
    Cortez-Espinosa N; Cortés-Garcia JD; Martínez-Leija E; Rodríguez-Rivera JG; Barajas-López C; González-Amaro R; Portales-Pérez DP
    Hum Immunol; 2015 Sep; 76(9):622-30. PubMed ID: 26386144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
    Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
    Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.
    Correale P; Rotundo MS; Del Vecchio MT; Remondo C; Migali C; Ginanneschi C; Tsang KY; Licchetta A; Mannucci S; Loiacono L; Tassone P; Francini G; Tagliaferri P
    J Immunother; 2010 May; 33(4):435-41. PubMed ID: 20386463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.
    Tang Y; Jiang L; Zheng Y; Ni B; Wu Y
    BMC Immunol; 2012 Apr; 13():17. PubMed ID: 22489829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
    Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
    PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
    Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
    Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
    Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
    PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.